These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30175189)

  • 41. Sleepiness, occlusion, dental arch and palatal dimensions in children attention deficit hyperactivity disorder (ADHD).
    Andersson H; Sonnesen L
    Eur Arch Paediatr Dent; 2018 Apr; 19(2):91-97. PubMed ID: 29542042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Comparison of Effectiveness of Parent Behavioral Management Training and Methylphenidate on Reduction of Symptomsof Attention Deficit Hyperactivity Disorder.
    Mohammadi MR; Soleimani AA; Ahmadi N; Davoodi E
    Acta Med Iran; 2016 Aug; 54(8):503-509. PubMed ID: 27701720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study.
    Baziar S; Aqamolaei A; Khadem E; Mortazavi SH; Naderi S; Sahebolzamani E; Mortezaei A; Jalilevand S; Mohammadi MR; Shahmirzadi M; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):205-212. PubMed ID: 30741567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mood and Proneness to Boredom Are Associated with Poorer Continuous Performance Test Results, Which May Improve with Methylphenidate Treatment, in Attention-Deficit/Hyperactivity Disorder.
    Golubchik P; Schoen G; Weizman A
    J Child Adolesc Psychopharmacol; 2021 May; 31(4):310-314. PubMed ID: 33956509
    [No Abstract]   [Full Text] [Related]  

  • 45. Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder.
    Balázs J; Dallos G; Keresztény A; Czobor P; Gádoros J
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):133-8. PubMed ID: 21486166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder?
    Reinhardt MC; Benetti L; Victor MM; Grevet EH; Belmonte-de-Abreu P; Faraone SV; Rohde LA
    J Clin Psychiatry; 2007 Jul; 68(7):1109-16. PubMed ID: 17685750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD).
    Treister R; Eisenberg E; Demeter N; Pud D
    Pain Pract; 2015 Jan; 15(1):4-11. PubMed ID: 24134430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effect of Methylphenidate on Neurological Soft Signs in ADHD.
    Hrtanek I; Ondrejka I; Tonhajzerova I; Snircova E; Kulhan T; Farsky I; Nosalova G
    Psychiatry Investig; 2015 Oct; 12(4):545-50. PubMed ID: 26508967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of methylphenidate treatment on psychopathic behavior of patients having attention-deficit hyperactivity disorder with and without oppositional defiant disorder.
    Golubchik P; Levy T; Weizman A
    Int Clin Psychopharmacol; 2018 Nov; 33(6):330-333. PubMed ID: 29958238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of changes in the macula and optic nerve head using optical coherence tomography in patients with attention deficit hyperactivity disorder.
    Sánchez-Guillén I; Almorín-Fernández-Vigo I; Fernández-Vigo JI; de-Pablo-Gómez-de-Liaño L; Kudsieh B; Fernández-Vigo JA
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jun; 95(6):271-278. PubMed ID: 32423628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical factors associated with decision to recommend methylphenidate treatment for children with ADHD in France.
    Courtabessis E; Pupier F; Surig L; Picot MC; Nogué E; Macioce V; Stein E; Purper-Ouakil D
    Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):367-376. PubMed ID: 28983797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment Predicament for Pediatric Dentist: Gender-wise Comparative Correlation of Biological and Chronological Age in 8-15-year-old Children.
    Gandhi K; Malhotra R; Datta G; Kapoor R; Jangra B; Pande P
    Int J Clin Pediatr Dent; 2022; 15(5):569-574. PubMed ID: 36865711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S; Mohammadi MR; Khademi M
    BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Effect of Previous Methylphenidate Use on Incidence of Stress Fractures in Military Recruits: A Retrospective Cohort.
    Ben-Ami IS; Ankory R; Kadar A; Rotman D; Snir N; Schermann H
    J Bone Joint Surg Am; 2018 Jun; 100(11):930-935. PubMed ID: 29870443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.
    Walitza S; Melfsen S; Herhaus G; Scheuerpflug P; Warnke A; Müller T; Lange KW; Gerlach M
    J Neural Transm Suppl; 2007; (72):311-5. PubMed ID: 17982908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of methylphenidate in auditory processing evaluation of children and adolescents with attention deficit hyperactivity disorder].
    Cavadas M; Pereira LD; Mattos P
    Arq Neuropsiquiatr; 2007 Mar; 65(1):138-43. PubMed ID: 17420844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit-hyperactivity disorder (ADHD).
    Amiri A; Torabi Parizi G; Kousha M; Saadat F; Modabbernia MJ; Najafi K; Atrkar Roushan Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():20-4. PubMed ID: 23933054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.